A detailed history of Entry Point Capital, LLC transactions in Orasure Technologies Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 101,205 shares of OSUR stock, worth $328,916. This represents 0.16% of its overall portfolio holdings.

Number of Shares
101,205
Previous 28,144 259.6%
Holding current value
$328,916
Previous $120,000 204.17%
% of portfolio
0.16%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$3.58 - $4.4 $261,558 - $321,468
73,061 Added 259.6%
101,205 $365,000
Q3 2024

Nov 13, 2024

BUY
$3.93 - $4.59 $110,605 - $129,180
28,144 New
28,144 $120,000
Q1 2024

May 14, 2024

SELL
$6.08 - $8.28 $145,968 - $198,786
-24,008 Reduced 93.36%
1,708 $10.5 Million
Q4 2023

Feb 14, 2024

BUY
$5.13 - $8.35 $131,923 - $214,728
25,716 New
25,716 $211 Million

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $236M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.